Navigation Links
New Guidelines Issued for Implanted Heart Devices
Date:5/15/2008

Prevention is as important as intervention, specialists say

THURSDAY, May 15 (HealthDay News) -- New guidelines for implanted heart devices such as pacemakers and defibrillators emphasize that they're just one aspect of cardiac care.

"This is a very specific statement of the importance of optimized medical care," Dr. Andrew Epstein, professor of medicine at the University of Alabama at Birmingham's Division of Cardiovascular Disease, said as he introduced the guidelines Thursday at the Heart Rhythm Society annual meeting, in San Francisco.

The guidelines "will be of tremendous importance not only to cardiologists, but also all physicians as well as the community at large," added Dr. Richard Page, head of the division of cardiology at the University of Washington School of Medicine and program chair of the meeting.

An estimated 180,000 pacemakers and 91,000 defibrillators were implanted in Americans in 2005. Pacemakers keep hearts beating regularly; defibrillators deliver an electric shock to restart an arrested heart or help an irregularly beating heart to return to normal.

The new guidelines update those published in 2002 on implanted cardiac devices. "They are as evidence-based as can possibly be," using information gathered in scores of controlled trials, Epstein said.

The committee drawing up the guidelines included members from the American College of Cardiology, the American Heart Association and the Heart Rhythm Society. The guidelines were expected to be published in the journals and posted on the Web sites of all three organizations.

One important aspect of the new guidelines is that it points out the value of implanted devices in preventing serious coronary problems, rather than being used after such problems occur, Epstein said.

Another important change is that "we have expanded the section on heart failure greatly," Epstein said. Heart failure, which is the progressive loss of the ability to pump blood, is a major contributor to cardiac mortality. An implanted device should be used only if symptoms persist when someone with heart failure already is receiving optimum drug therapy, with medications such as ACE inhibitors and beta blockers, the committee wrote.

The new guidelines also note the importance of talking about the risks and benefits of implanted devices with the patient and family. "We've always tried to do that, and it is formally articulated in the guidelines," Epstein said.

The emphasis on considering implanted devices as one part of an overall strategy arises partly from the greatly expanded used of cardiac medications. For example, more than 80 percent of Americans with coronary disease now get beta blockers, he said.

"We emphasize that the global approach to patients saves lives," Epstein said.

More information

Learn more about heart devices from the U.S. Food and Drug Administration.



SOURCES: Andrew Epstein, M.D., professor of medicine, University of Alabama at Birmingham's Division of Cardiovascular Disease; Richard Page, M.D., head of the division of cardiology, University of Washington School of Medicine, Seattle; May 15, 2008, presentation, Heart Rhythm Society annual meeting, San Francisco


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. The American College of Cardiology, American Heart Association and the Heart Rhythm Society Release Updated Cardiac Device-Based Therapy Guidelines
2. ASGE issues updated infection control guidelines for gastrointestinal endoscopy
3. ASGE issues updated guidelines on antibiotic prophylaxis for gastrointestinal endoscopy
4. AAPA Endorses 2008 Public Health Service Guidelines for Treating Tobacco Use and Dependence
5. New Guidelines Show Smokers Have More Tools to Quit Than Ever, But Elected Officials Must Do More to Help
6. Complimentary Excerpt Available from Best Practices: Pharmaceutical Competitive Intelligence Excellence - Optimizing Data Collection within Approved Guidelines
7. Boise(R) BEWARE(R) Meets April 1 Federal Medicaid Guidelines Requiring Tamper-Resistant Prescription Paper
8. Dust Mites Trump Asthma Prevention Guidelines
9. Patient Centered Primary Care Collaborative Releases New Guidelines for Health Care Purchasers
10. Clinical guidelines for the manual titration of PAP in OSA patients published in JCSM
11. Schering-Plough Announces Expanded Stock Retention Guidelines for Senior Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... CALNOC, the nation’s first and ... keynote their upcoming conference – Empowerment, Value and Collaboration – in Seattle, WA on ... of the Virginia Mason Health System in Seattle since 2000. In addition to his ...
(Date:2/23/2017)... , ... February 23, 2017 , ... Thomas Vas-Don ... and disciplined exercise regime, the author was able to successfully recover. In “ Origin ... relevant information for various sources on the principals of massage, anatomy , ...
(Date:2/22/2017)... Boca Raton, FL (PRWEB) , ... February 22, 2017 , ... ... made primarily from deer antler velvet, announced its products are coming soon to Amazon.com, ... by Clint and Shelley Thomson as a means to develop an effective natural treatment ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... certification exam and eligibility requirements effective with the April 2017 testing period. NACCM, ... , “The Care Manager Certified (CMC) exam is periodically re-calibrated to ensure ...
(Date:2/22/2017)... ... February 22, 2017 , ... In a 2012 survey, ... or not filling a prescription because they could not afford to pay for ... medications were 30-60%*. At the same time, hospitals, pharmacies, manufacturers and ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... On Wednesday, February 22, 2017, US ... of nine sectors finished the trading sessions in green, four ... Major US indices were also mixed at the close of ... slightly down by 0.09%; the Dow Jones Industrial Average edged ... closed at 2,362.82, down 0.11%. This Thursday morning, Stock-Callers.com looks ...
(Date:2/23/2017)... 2017 ML Capital Group, Inc. (USOTC: MLCG) ... Highlife Tours , a Colorado -based cannabis ... Puration, Inc. (USOTC: PURA) to enter Colorado,s ... Colorado Highlife Tours acquisition announced today is intended to accelerate MLCG,s ... ...
(Date:2/23/2017)... and VANCOUVER, British Columbia , ... OGXI ) today announced its year end 2016 ... In January 2017, OncoGenex, and Achieve Life Science, Inc., ... have entered into a definitive merger agreement under which ... completion of the proposed merger, Achieve,s stockholders are expected ...
Breaking Medicine Technology: